Journal of Korean Medical Science

Korean Acad Medical Sciences (대한의학회)
권호 표지
DOI QR코드

DOI QR Code

The Prevalence of Marfan Syndrome in Korea

  • Jang, Shin Yi (Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Seo, Su Ra (The National Health Insurance Service) ;
  • Park, Seung Woo (Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Duk-Kyung (Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2016.10.07
  • Accepted : 2017.01.20
  • Published : 2017.04.10
⟨ Previous Next ⟩

Abstract

The aim of this study was to assess the prevalence of Marfan syndrome (MFS) in Korean adults. Data were collected from the National Health Insurance Service in Korea from 2006 through 2013. The data consisted of primary diagnoses related to MFS (Q87.4) diagnosed according to the 10th revision of the International Statistical Classification of Diseases and Related Health Problems. The age-standardized prevalence of MFS in adults was calculated using the estimated Korean population in 2010 as a reference. Overall, the prevalence of MFS was 0.90 per 100,000 persons in 2006 and 2.27 in 2013. For males in 2013, the prevalence per 100,000 persons was 2.61 in overall and 4.32 in 15-19 years-old. For females in 2013, the prevalence per 100,000 persons was 1.92 in overall and 3.02 in 10-14 years-old. In conclusion, currently, the age-standardized overall prevalence of MFS was 2.27 persons per 100,000 persons. And the overall age-standardized prevalence of MFS increased between 2006 and 2013 especially in 15-19 years-old males and 10-14 years-old females.

Keywords

References

  1. Kainulainen K, Karttunen L, Puhakka L, Sakai L, Peltonen L. Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome. Nat Genet 1994; 6: 64-9. https://doi.org/10.1038/ng0194-64
  2. Dietz HC, Loeys B, Carta L, Ramirez F. Recent progress towards a molecular understanding of Marfan syndrome. Am J Med Genet C Semin Med Genet 2005; 139C: 4-9. https://doi.org/10.1002/ajmg.c.30068
  3. McKusick VA. The defect in Marfan syndrome. Nature 1991; 352: 279-81. https://doi.org/10.1038/352279a0
  4. Robbins SL, Cotran RS, Kumar V. Pocket Companion to Pathologic Basis of Disease. Philadelphia, PA, W.B. Saunders Company, 1991.
  5. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006; 312: 117-21. https://doi.org/10.1126/science.1124287
  6. Groth KA, Hove H, Kyhl K, Folkestad L, Gaustadnes M, Vejlstrup N, Stochholm K, Ostergaard JR, Andersen NH, Gravholt CH. Prevalence, incidence, and age at diagnosis in Marfan syndrome. Orphanet J Rare Dis 2015; 10: 153. https://doi.org/10.1186/s13023-015-0369-8
  7. Keane MG, Pyeritz RE. Medical management of Marfan syndrome. Circulation 2008; 117: 2802-13. https://doi.org/10.1161/CIRCULATIONAHA.107.693523
  8. De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996; 62: 417-26. https://doi.org/10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R
  9. Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, Hilhorst-Hofstee Y, Jondeau G, Faivre L, Milewicz DM, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet 2010; 47: 476-85. https://doi.org/10.1136/jmg.2009.072785
  10. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Philadelpia, PA, Lippincott Williams & Winkins, 2008.
  11. National Health Insurance Service (KR); Health Insurance Review & Assessment Service (KR). National Health Insurance Statistical Yearbook: 2006 [Internet]. Available at http://www.nhis.or.kr/menu/boardRetriveMenuSet.xx?menuId=F3321 [accessed on 20 December 2016].
  12. National Health Insurance Service (KR); Health Insurance Review & Assessment Service (KR). National Health Insurance Statistical Yearbook: 2007 [Internet]. Available at http://www.nhis.or.kr/menu/boardRetriveMenuSet.xx?menuId=F3321 [accessed on 20 December 2016].
  13. National Health Insurance Service (KR); Health Insurance Review & Assessment Service (KR). National Health Insurance Statistical Yearbook: 2008 [Internet]. Available at http://www.nhis.or.kr/menu/boardRetriveMenuSet.xx?menuId=F3321 [accessed on 20 December 2016].
  14. National Health Insurance Service (KR); Health Insurance Review & Assessment Service (KR). National Health Insurance Statistical Yearbook: 2009 [Internet]. Available at http://www.nhis.or.kr/menu/boardRetriveMenuSet.xx?menuId=F3321 [accessed on 20 December 2016].
  15. National Health Insurance Service (KR); Health Insurance Review & Assessment Service (KR). National Health Insurance Statistical Yearbook: 2010 [Internet]. Available at http://www.nhis.or.kr/menu/boardRetriveMenuSet.xx?menuId=F3321 [accessed on 20 December 2016].
  16. National Health Insurance Service (KR); Health Insurance Review & Assessment Service (KR). National Health Insurance Statistical Yearbook: 2011 [Internet]. Available at http://www.nhis.or.kr/menu/boardRetriveMenuSet.xx?menuId=F3321 [accessed on 20 December 2016].
  17. National Health Insurance Service (KR); Health Insurance Review & Assessment Service (KR). National Health Insurance Statistical Yearbook: 2012 [Internet]. Available at http://www.nhis.or.kr/menu/boardRetriveMenuSet.xx?menuId=F3321 [accessed on 20 December 2016].
  18. National Health Insurance Service (KR); Health Insurance Review & Assessment Service (KR). National Health Insurance Statistical Yearbook: 2013 [Internet]. Available at http://www.nhis.or.kr/menu/boardRetriveMenuSet.xx?menuId=F3321 [accessed on 20 December 2016].
  19. Korean Statistical Information Service. Census [Internet]. Available at http: //kosis.kr/statisticsList/statisticsList_01List.jsp?vwcd=MT_ZTITLE&parentId =A [accessed on 1 December 2016].
  20. Jang SY, Ju EY, Seo SR, Choi JY, Park SJ, Kim DK, Park SW. Changes in the etiology of valvular heart disease in the rapidly aging Korean population. Int J Cardiol 2014; 174: 355-9. https://doi.org/10.1016/j.ijcard.2014.04.112
  21. Chiu HH, Wu MH, Chen HC, Kao FY, Huang SK. Epidemiological profile of Marfan syndrome in a general population: a national database study. Mayo Clin Proc 2014; 89: 34-42. https://doi.org/10.1016/j.mayocp.2013.08.022
  22. Kwun Y, Kim SJ, Lee J, Isojima T, Choi DS, Kim DK, Huh J, Kang IS, Chang M, Cho SY, et al. Disease-specific growth charts of Marfan syndrome patients in Korea. J Korean Med Sci 2015; 30: 911-6. https://doi.org/10.3346/jkms.2015.30.7.911
  23. Korean Statistical Information Service. Specific equipments by type of medical care institutions [Internet]. Available at http://kosis.kr/statisticsList/statisticsList_01List.jsp?vwcd=MT_ZTITLE&parentId=D [accessed on 1 December 2016].
  24. Lim AY, Song JS, Kim EK, Jang SY, Chung TY, Choi SH, Sung K, Huh J, Kang IS, Choe YH, et al. Clinical characteristics of Marfan syndrome in Korea. Korean Circ J 2016; 46: 841-5. https://doi.org/10.4070/kcj.2016.46.6.841
  25. Yuan SM, Jing H. Marfan's syndrome: an overview. Sao Paulo Med J 2010; 128: 360-6. https://doi.org/10.1590/S1516-31802010000600009

Cited by

  1. Prevalence of Amyloidosis in Korea vol.12, pp.None, 2017, https://doi.org/10.1186/s13023-017-0705-2
  2. Prevalence and mortality of congenital heart disease in Korean adults vol.97, pp.27, 2017, https://doi.org/10.1097/md.0000000000011348
  3. Impact of Atrial Fibrillation on Survival in Adults with Congenital Heart Disease: a Retrospective Population-based Study vol.36, pp.5, 2021, https://doi.org/10.3346/jkms.2021.36.e43